Cargando…

β-Catenin Expression and Activation in Conjunctival Melanoma

PURPOSE: To assess the role of the canonical Wnt pathway via activation of β-catenin in tumor progression of conjunctival melanoma. METHODS: β-Catenin localization was assessed by immunohistochemistry in 43 conjunctival nevi, 48 primary acquired melanoses (PAM; conjunctival melanocytic intraepitheli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larivé, Emerentienne, Nicolas, Michael, Kaya, Gürkan, Riggi, Nicolo, Moulin, Alexandre P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827456/ https://www.ncbi.nlm.nih.gov/pubmed/31700844 http://dx.doi.org/10.1159/000500682

Ejemplares similares

5-Hydroxymethylcytosine Loss in Conjunctival Melanoma
por: Stahl, Alexandre, et al.
Publicado: (2021)

Genomic and transcriptomic landscape of conjunctival melanoma
por: Cisarova, Katarina, et al.
Publicado: (2020)

Identification of New Vulnerabilities in Conjunctival Melanoma Using Image-Based High Content Drug Screening
por: Nardou, Katya, et al.
Publicado: (2022)

Conjunctival melanoma
por: de Abreu, Marilda Aparecida Milanez Morgado, et al.
Publicado: (2018)

Wnt/β-catenin signaling stimulates the self-renewal of conjunctival stem cells and promotes corneal conjunctivalization
por: Jang, Esther, et al.
Publicado: (2022)

UV light signature in conjunctival melanoma; not only skin should be protected from solar radiation
por: Rivolta, Carlo, et al.
Publicado: (2016)

Expression of VEGF in human conjunctival melanoma analyzed with immunohistochemistry
por: Kase, Satoru, et al.
Publicado: (2018)

Synchronous conjunctival melanoma and lentigo maligna melanoma
por: Volpini, Beatrice Mussio Fornazier, et al.
Publicado: (2017)

Trends in Incidence of Conjunctival Melanoma in the US
por: Weppelmann, Thomas A., et al.
Publicado: (2022)

Management Issues in Conjunctival Tumours: Conjunctival Melanoma and Primary Acquired Melanosis
por: Cohen, Victoria M. L., et al.
Publicado: (2019)

NF1 mutations in conjunctival melanoma
por: Scholz, S. L., et al.
Publicado: (2018)

Orbital exenteration and conjunctival melanoma: a 14-year study at the Jules Gonin Eye Hospital
por: Martel, A., et al.
Publicado: (2020)

Systemic Treatment of Metastatic Conjunctival Melanoma
por: Pinto Torres, Simão, et al.
Publicado: (2017)

Conjunctival melanoma in an African American man
por: Oh, Daniel Jungmyung, et al.
Publicado: (2020)

Amelanotic conjunctival melanoma in a child
por: Vishnevskia-Dai, Vicktoria, et al.
Publicado: (2022)

Conjunctival Melanoma: A Case Presentation
por: Montazer, Fatemeh, et al.
Publicado: (2023)

Prognosis of conjunctival melanomas in relation to histopathological features.
por: Fuchs, U., et al.
Publicado: (1989)

Tumour-associated lymphangiogenesis in conjunctival malignant melanoma
por: Zimmermann, P, et al.
Publicado: (2009)

PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome
por: Lassalle, Sandra, et al.
Publicado: (2020)

Compound Nevus Simulating a Conjunctival Melanoma
por: Gupta, Parul Chawla, et al.
Publicado: (2018)

Conjunctival Pyogenic Granuloma Masquerading as Malignant Melanoma
por: Rao, Priyanka R, et al.
Publicado: (2021)

Update on Immune Checkpoint Inhibitors for Conjunctival Melanoma
por: Sa, Ho-Seok, et al.
Publicado: (2022)

A Conjunctival Melanoma with Invasion of the Nasolacrimal Duct
por: Matsunaga, Takuma, et al.
Publicado: (2022)

ATRX Loss in the Development and Prognosis of Conjunctival Melanoma
por: van Ipenburg, Jolique A., et al.
Publicado: (2023)

Genetic Aspects of Conjunctival Melanoma: A Review
por: Chang, Emily, et al.
Publicado: (2023)

Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome
por: Kenawy, Nihal, et al.
Publicado: (2019)

Conjunctival Melanoma: A New Clinical and Therapeutical Approach
por: Rodríguez-Martín, M., et al.
Publicado: (2010)

Incidence and Mortality of Conjunctival Melanoma in Australia (1982 to 2014)
por: Beasley, Aaron B., et al.
Publicado: (2023)

Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma
por: Cao, Jinfeng, et al.
Publicado: (2017)

Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Conjunctival melanoma: a review of conceptual and treatment advances
por: Lim, Li-Anne, et al.
Publicado: (2013)

Conjunctival melanoma in a child: A clinicopathological report
por: Yangzes, Sonam, et al.
Publicado: (2018)

Tarsoconjunctival flap for scleromalacia related to treatments for conjunctival melanoma
por: Finger, Paul T., et al.
Publicado: (2023)

Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth
por: Uka, Rexhep, et al.
Publicado: (2020)

Melanorrhea: Noncontiguous spread of palpebral conjunctival melanoma to the nasolacrimal duct
por: Rao, Raksha, et al.
Publicado: (2018)

Activation of Wnt/β-Catenin Signaling Increases Apoptosis in Melanoma Cells Treated with Trail
por: Zimmerman, Zachary F., et al.
Publicado: (2013)

Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma
por: Trujillo, Jonathan A., et al.
Publicado: (2019)

Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
por: Brouwer, Niels J., et al.
Publicado: (2021)

Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy
por: Cao, Jinfeng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5i0u62uj4cma80vs5haes2grk2